US Patent 11964968 Compounds useful for inhibiting RET kinase
Patent 11964968 was granted and assigned to Eli Lilly and Company on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
US Patent 11964968 Compounds useful for inhibiting RET kinase
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elizabeth A. McFaddin0
Erin D. Anderson0
Gabrielle R. Kolakowski0
Kevin R. Condroski0
Manoj Kumar0
Megan McKenney0
Michael B. Welch0
Michael J. Munchhof0
Steven W. Andrews0
Thomas C. Irvin0
Date of Patent
April 23, 2024
0Patent Application Number
181650370
Date Filed
February 6, 2023
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11964968 Compounds useful for inhibiting RET kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
